Company intelligence / Profile preview

Advanced Circulatory Systems

Roseville, Minnesota, United Statesbiospace.com ↗

Ownership: Private
Development stage: Other

Overview

The company’s ResQCPR System—a combination of the ResQPOD ITD and ResQPUMP ACD—received FDA approval in 2015 as the only CPR adjunct indicated to improve survival from cardiac arrest. Clinical studies demonstrated a significant increase in one-year survival rates when used versus standard CPR alone.

Earlier products like the ResQPOD ITD received FDA clearance in 2003. Multiple clinical studies have shown improved blood flow to heart and brain during resuscitation.

Therapeutic areas: NeurologyCardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

US Army Institute of Surgical Research via SBIR program for product development and impact assessment on military populations.

Beyond the preview

Go deeper on Advanced Circulatory Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Circulatory Systems.

Explore the full profile